Počet záznamů: 1  

The pH-dependent and enzymatic release of cytarabine from hydrophilic polymer conjugates

  1. 1.
    0463652 - ÚMCH 2017 RIV CZ eng J - Článek v odborném periodiku
    Pola, Robert - Janoušková, Olga - Etrych, Tomáš
    The pH-dependent and enzymatic release of cytarabine from hydrophilic polymer conjugates.
    Physiological Research. Roč. 65, Suppl. 2 (2016), S225-S232. ISSN 0862-8408. E-ISSN 1802-9973
    Grant CEP: GA MŠMT(CZ) LO1507
    Institucionální podpora: RVO:61389013
    Klíčová slova: HPMA copolymers * drug delivery system * nucleoside analogues
    Kód oboru RIV: CD - Makromolekulární chemie
    Impakt faktor: 1.461, rok: 2016
    http://www.biomed.cas.cz/physiolres/pdf/65%20Suppl%202/65_S225.pdf

    Cytarabine is one of the most efficient drugs in the treatment of hematological malignancies. In this work, we describe the synthesis and characterization of two different polymer conjugates of cytarabine that were designed for the controlled release of cytarabine within the leukemia cells. Reactive copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) and 3-(3-methacrylamidopropanoyl)thiazolidine-2-thione) or 3-(Nmethacryloylglycyl-phenylalanylleucylglycyl)thiazolidine-2-thione were used in the study as reactive polymer precursors for reaction with cytarabine. The enzymatic release of cytarabine from the conjugate containing a GFLG spacer utilizing cathepsin B was verified. In addition to enzymolysis, the pH-dependent hydrolysis of cytarabine from both copolymers was also confirmed. Approximately 40 % and 20 % of the drug was released by spontaneous hydrolysis at pH 7.4 within 72 h from the polymer conjugates with the GFLG and beta-Ala spacers, respectively. At pH 6.0, the spontaneous hydrolysis slowed down, and less than 10 % of the drug was liberated within 72 h. The results of the cytotoxicity evaluation of the polymer conjugates in vitro against various cell lines showed that the cytotoxicity of the polymer conjugates is approximately three times lower in comparison to free cytarabine.
    Trvalý link: http://hdl.handle.net/11104/0264458

     
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.